Andrade Robert

Track

Insider profile

Andrade Robert's trades of Fennec Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-27 2024-03-26
PlS Planned sale
73,890 -45.7%
10.89
US$4,115,355 		73,890 -45.7% 10.89 US$4,115,355
2024-03-26 2024-03-26
PrS Proposed sale
10,645
339.09
US$2,858,152 		10,645 339.09 US$2,858,152
2024-03-25 2024-03-25
PrS Proposed sale
623
413.41
US$3,463,208 		623 413.41 US$3,463,208
2024-03-25 2024-03-25
PlS Planned sale
13,975 -11.7%
11.00
US$153,690 		13,975 -11.7% 11.00 US$153,690
2024-01-05 2024-01-05
PrS Proposed sale
15,000
10.41
US$156,118 		15,000 10.41 US$156,118
2024-01-05 2024-01-05
PlS Planned sale
15,000 -11.1%
10.41
US$156,150 		15,000 -11.1% 10.41 US$156,150
2024-01-05 2024-01-04
PlS Planned sale
15,000 -10.0%
10.64
US$159,600 		15,000 -10.0% 10.64 US$159,600
2024-01-04 2024-01-04
PrS Proposed sale
15,000
10.64
US$159,616 		15,000 10.64 US$159,616
2023-06-29 2023-06-29
PrS Proposed sale
7,500
8.97
US$67,300 		7,500 8.97 US$67,300
2023-06-28 2023-06-28
PrS Proposed sale
10,000
8.99
US$89,899 		10,000 8.99 US$89,899
2022-12-30 2022-12-30
PlS Planned sale
5,500 -3.5%
9.61
US$52,867 		5,500 -3.5% 9.61 US$52,867
2022-12-30 2022-12-29
PlS Planned sale
5,500 -3.4%
9.57
US$52,661 		5,500 -3.4% 9.57 US$52,661
2022-12-30 2022-12-28
PlS Planned sale
11,000 -6.4%
9.61
US$105,760 		11,000 -6.4% 9.61 US$105,760